TrialBMC cancer2015

Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response.

Winnie Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.